TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 0.210nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 0.230nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 0.630nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 0.830nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 0.850nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 0.900nMAssay Description:Inhibition of human TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 1.5nMAssay Description:Inhibition of human TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 1.65nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 2.20nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 3.25nMpH: 5.0Assay Description:Inhibition of rat TRPV1 at pH 5 to 5.5More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibition of human TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 6.10nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 7.10nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 14nMAssay Description:Inhibition of human TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibition of human TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 29nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Rattus norvegicus (rat))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 32nMAssay Description:Inhibition of rat TRPV1More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 79nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 308nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 460nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Neurogen Corporation
Curated by ChEMBL
Neurogen Corporation
Curated by ChEMBL
Affinity DataIC50: 665nMAssay Description:Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsazepine-induced calcium mobilization by FLIPR ...More data for this Ligand-Target Pair
Affinity DataIC50: 980nMAssay Description:Inhibition of human ERK1More data for this Ligand-Target Pair
